Aju Ib Investment Co., Ltd. Rapt Therapeutics, Inc. Transaction History
Aju Ib Investment Co., Ltd.
- $91.6 Million
- Q2 2025
A detailed history of Aju Ib Investment Co., Ltd. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Aju Ib Investment Co., Ltd. holds 12,437 shares of RAPT stock, worth $127,230. This represents 0.11% of its overall portfolio holdings.
Number of Shares
12,437
Previous 99,503
87.5%
Holding current value
$127,230
Previous $121,000
18.18%
% of portfolio
0.11%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding RAPT
# of Institutions
95Shares Held
111MCall Options Held
41.3KPut Options Held
100-
Orbimed Advisors LLC San Diego, CA13.1MShares$134 Million0.5% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$134 Million3.85% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$128 Million8.35% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$120 Million0.24% of portfolio
-
Bvf Inc San Francisco, CA9.24MShares$94.5 Million0.5% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $303M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...